The formation of inflammatory demyelinated lesions in cerebral white matter

Annals of Neurology

Volumn 76, Issue 4, 2014, Pages 594-608

  Maggi, Pietro ^a,b   Cummings Macri, Sheila M ^c   Gaitán, María I ^a   Leibovitch, Emily ^a,d   Wholer, Jillian E ^a   Knight, Heather L ^c   Ellis, Mary ^c   Wu, Tianxia ^a   Silva, Afonso C ^a   Massacesi, Luca ^a,b   Jacobson, Steven ^a   Westmoreland, Susan ^c   Reich, Daniel S ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSITY OF FLORENCE   (Italy)

^c HARVARD MEDICAL SCHOOL   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; ACTIN BINDING PROTEIN; CALGRANULIN; CONTRAST MEDIUM; GLIAL FIBRILLARY ACIDIC PROTEIN;

ANALYSIS OF VARIANCE; ANIMAL; BLOOD BRAIN BARRIER; BRAIN CORTEX; CALLITHRIX; COMPLICATION; DIAGNOSTIC USE; DISEASE MODEL; ENCEPHALITIS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; IMAGE PROCESSING; MALE; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; WHITE MATTER;

2',3'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; ANALYSIS OF VARIANCE; ANIMALS; BLOOD-BRAIN BARRIER; CALLITHRIX; CEREBRAL CORTEX; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; ENCEPHALITIS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; IMAGE PROCESSING, COMPUTER-ASSISTED; LEUKOCYTE L1 ANTIGEN COMPLEX; MAGNETIC RESONANCE IMAGING; MALE; MICROFILAMENT PROTEINS; WHITE MATTER;

EID: 84907812596     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24242     Document Type: Article

References (46)

1. Lassmann H, Brück W, Lucchinetti CF. The immunopathology of multiple sclerosis: an overview. Brain Pathol 2007;17:210-218.
2. Filippi M, Rocca MA, Martino G, et al. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 1998;43:809-814.
3. Fazekas F, Ropele S, Enzinger C. Quantitative magnetization transfer imaging of pre-lesional white-matter changes in multiple sclerosis. Mult Scler 2002;8:479-484.
4. Goodkin DE, Rooney WD, Sloan R, et al. A serial study of new MS lesions and the white matter from which they arise. Neurology 1998;51:1689-1697.
5. Laule C, Vavasour IM, Whittall KP, et al. Evolution of focal and diffuse magnetisation transfer abnormalities in multiple sclerosis. J Neurol 2003;250:924-931.
6. Wuerfel J. Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. Brain 2004;127:111-119.
7. Werring DJ, Brassat D, Droogan AG, et al. The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study. Brain 2000;123(pt 8):1667-1676.
8. Wiggermann V, Hernández Torres E, Vavasour IM, et al. Magnetic resonance frequency shifts during acute MS lesion formation. Neurology 2013;81:211-218.
9. Katz D, Taubenberger JK, Cannella B, et al. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993;34:661-669.
10. Grossman RI, Gonzalez-Scarano F, Atlas SW, et al. Multiple sclerosis: gadolinium enhancement in MR imaging. Radiology 1986;161:721-725.
11. De Groot CJ, Bergers E, Kamphorst W, et al. Post-mortem MRIguided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. Brain 2001;124(pt 8):1635-1645.
12. van Horssen J, Singh S, van der Pol S, et al. Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation. J Neuroinflammation 2012;9:156.
13. Henderson APD, Barnett MH, Parratt JDE, Prineas JW. Multiple sclerosis: distribution of inflammatory cells in newly forming lesions. Ann Neurol 2009;66:739-753.
14. Davalos D, Ryu JK, Merlini M, et al. Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat Commun 2012;3:1227.
15. Marik C, Felts PA, Bauer J, et al. Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? Brain 2007;130(pt 11):2800-2815.
16. 't Hart BA, Massacesi L. Clinical, pathological, and immunologic aspects of the multiple sclerosis model in common marmosets (Callithrix jacchus). J Neuropathol Exp Neurol 2009;68:341-355.
17. Gaitán MI, Maggi P, Wohler J, et al. Perivenular brain lesions in a primate multiple sclerosis model at 7-tesla magnetic resonance imaging. Mult Scler 2014;20:64-71.
18. Leibovitch E, Wohler JE, Cummings Macri SM, et al. Novel marmoset (Callithrix jacchus) model of human herpesvirus 6A and 6B infections: immunologic, virologic and radiologic characterization. PLoS Pathog 2013;9:e1003138.
19. Liu JV, Bock NA, Silva AC. Rapid high-resolution three-dimensional mapping of T1 and age-dependent variations in the nonhuman primate brain using magnetization-prepared rapid gradient-echo (MPRAGE) sequence. Neuroimage 2011;56:1154-1163.
20. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-232.
21. Imai Y, Ibata I, Ito D, et al. A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem Biophys Res Commun 1996;224:855-862.
22. Lassmann H. Review: The architecture of inflammatory demyelinating lesions: implications for studies on pathogenesis. Neuropathol Appl Neurobiol 2011;37:698-710.
23. Brück W, Porada P, Poser S, et al. Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol 1995;38:788-796.
24. Soulas C, Conerly C, Kim W-K, et al. Recently Infiltrating MAC3871 monocytes/macrophages. Am J Pathol 2011;178:2121-2135.
25. Pomeroy IM, Matthews PM, Frank JA, et al. Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis. Brain 2005;128(pt 11):2713-2721.
26. Pomeroy I, Jordan E, Frank J, et al. Focal and diffuse cortical degenerative changes in a marmoset model of multiple sclerosis. Mult Scler 2010;16:537-548.
27. Merkler D, Böscke R, Schmelting B, et al. Differential macrophage/microglia activation in neocortical EAE lesions in the marmoset monkey. Brain Pathol 2006;16:117-123.
28. Kluver H, Barrera E. A method for the combined staining of cells and fibers in the nervous system. J Neuropathol Exp Neurol 1953;12:400-403.
29. Engelhardt B, Ransohoff RM. Capture, crawl, cross: the T cell code to breach the blood-brain barriers. Trends Immunol 2012;33:579-589.
30. Gaitán MI, Shea CD, Evangelou IE, et al. Evolution of the bloodbrain barrier in newly forming multiple sclerosis lesions. Ann Neurol 2011;70:22-29.
31. Lucchinetti CF, Popescu BFG, Bunyan RF, et al. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 2011;365:2188-2197.
32. Adams RD, Kubik CS. The morbid anatomy of the demyelinative disease. Am J Med 1952;12:510-546.
33. Prineas JW, Parratt JDE. Oligodendrocytes and the early multiple sclerosis lesion. Ann Neurol 2012;72:18-31.
34. Barnett MH, Prineas JW. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 2004;55:458-468.
35. Boche D, Perry VH, Nicoll JAR. Review: Activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol 2013;39:3-18.
36. Kiefer R, Kieseier BC, Brück W, et al. Macrophage differentiation antigens in acute and chronic autoimmune polyneuropathies. Brain 1998;121(pt 3):469-479.
37. Trebst C, Sørensen TL, Kivisakk P, et al. CCR11/CCR51 mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis. Am J Pathol 2001;159:1701-1710.
38. Hart BA, Bauer J, Muller HJ, et al. Histopathological characterization of magnetic resonance imaging-detectable brain white matter lesions in a primate model of multiple sclerosis: a correlative study in the experimental autoimmune encephalomyelitis model in common marmosets (Callithrix jacchus). Am J Pathol 1998;153:649-663.
39. Absinta M, Sati P, Gaitán MI, et al. Seven-tesla phase imaging of acute multiple sclerosis lesions: a new window into the inflammatory process. Ann Neurol 2013;74:669-678.
40. Initial investigation of the blood-brain barrier in MS lesions at 7 tesla. Mult Scler 2013;19:1068-1073.
41. Pesic M, Bartholomäus I, Kyratsous NI, et al. 2-photon imaging of phagocyte-mediated T cell activation in the CNS. J Clin Invest 2013;123:1192-1201.
42. Reboldi A, Coisne C, Baumjohann D, et al. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 2009;10:514-523.
43. Xu H, Manivannan A, Liversidge J, et al. Requirements for passage of T lymphocytes across non-inflamed retinal microvessels. J Neuroimmunol 2003;142:47-57.
44. Fabriek BO, van Haastert ES, Galea I, et al. CD163-positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation. Glia 2005;51:297-305.
45. Ransohoff RM, Engelhardt B. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol 2012;12:623-635.
46. Larochelle C, Alvarez JI, Prat A. How do immune cells overcome the blood-brain barrier in multiple sclerosis? FEBS Lett 2011;585:3770-3780.